JOHNSTOWN, PA--(MARKET WIRE)--Oct 6, 2008 -- EP Global Communications Inc. (OTC BB:EPGL.OB - News), the parent company of Exceptional Parent (EP) magazine, is pleased to announce today that its December issue, focusing on Family and Community, will include a feature story about John C. McGinley. McGinley is an established actor, producer, and screenwriter who is best known for his role as "Dr. Perry Cox" in the NBC comedy "Scrubs." He is also the father of Max, who has Down syndrome.

The article will feature information gained from a recent interview between McGinley and EP magazine where he discussed his initial reactions to learning that Max, now 11, had Down syndrome, his work with the National Down Syndrome Society, and his very strong opinion about the use of derogatory words against the special needs community and in describing those with disabilities.

The December issue of EP will be available to subscribers and can be purchased online at www.eparent.com.

About EP Global Communications, Inc.

EP Global Communications, Inc., parent company of Exceptional Parent (EP) magazine, is a 38-year-old, award-winning publishing and communications company which provides practical advice and emotional support to families of children and adults with disabilities and special healthcare needs as well as to the physicians, allied healthcare and educational professionals who are involved in their care and development. EP Global Communications, Inc. uses a multi-media approach to disseminate information via: its monthly award-winning publication, Exceptional Parent; Web site (www.eparent.com); clinical custom communications projects; the EP Bookstore (www.epbookstore.com) of disability books, DVDs and videos; live and online interactive CME/CEU accredited seminars & teleconferences on a wide range of special needs topics dealing with chronic, long term disabilities.

Safe Harbor Statement

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

     Contact:
     Jan Hollingsworth
     Managing Editor
     Phone: 814-361-3860 x291
     Email: Email Contact